Skip to main content
Fig. 1 | Trials

Fig. 1

From: Pharmacodynamics of Pre-Operative PD1 checkpoint blockade and receptor activator of NFkB ligand (RANKL) inhibition in non-small cell lung cancer (NSCLC): study protocol for a multicentre, open-label, phase 1B/2, translational trial (POPCORN)

Fig. 1

SPIRIT schedule of enrolment, interventions and assessments. ECG electrocardiogram, ECOG PS Eastern Cooperative Oncology Group Performance Status, CT computed tomography, FDG-PET fluorodeoxyglucose-position emission tomography, CBC complete blood count, U&E urea and electrolytes, LFT liver function test, TFT thyroid function test, PBMC peripheral blood mononuclear cells, AE adverse events, MPR major pathological response, Rx treatment, OS overall survival, PFS progression-free survival

Back to article page

Trials

ISSN: 1745-6215